deltatrials
Completed NA INTERVENTIONAL 1-arm NCT02162732

Molecular-Guided Therapy for Childhood Cancer

Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers

Sponsor: Dell, Inc.

Interventions Guided Therapy
Updated 19 times since 2017 Last updated: Oct 29, 2025 Started: Jul 8, 2014 Primary completion: Jan 18, 2024 Completion: Jan 18, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02162732, this NA trial focuses on Choroid Plexus Neoplasms and Clear Cell Sarcoma and remains completed. Sponsored by Dell, Inc., it has been updated 19 times since 2014, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~May 2017 · 3 months · monthly snapshot~May 2017 – ~Aug 2017 · 3 months · monthly snapshot~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Nov 2018 · 3 months · monthly snapshot~Nov 2018 – ~Aug 2019 · 9 months · monthly snapshot~Aug 2019 – ~Dec 2020 · 16 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Mar 2022 · 14 months · monthly snapshot~Mar 2022 – ~May 2022 · 2 months · monthly snapshot~May 2022 – ~Feb 2023 · 9 months · monthly snapshot~Feb 2023 – ~Oct 2023 · 8 months · monthly snapshot~Oct 2023 – ~May 2024 · 7 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – ~Dec 2025 · 3 months · monthly snapshot~Dec 2025 – present · 9 months · monthly snapshot

Change History

19 versions recorded
  1. Dec 2025 — Present [monthly]

    Completed NA

  2. Sep 2025 — Dec 2025 [monthly]

    Completed NA

  3. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  4. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  5. May 2024 — Jul 2024 [monthly]

    Completed NA

    Status: Active Not RecruitingCompleted

Show 14 earlier versions
  1. Oct 2023 — May 2024 [monthly]

    Active Not Recruiting NA

  2. Feb 2023 — Oct 2023 [monthly]

    Active Not Recruiting NA

  3. May 2022 — Feb 2023 [monthly]

    Active Not Recruiting NA

  4. Mar 2022 — May 2022 [monthly]

    Active Not Recruiting NA

  5. Jan 2021 — Mar 2022 [monthly]

    Active Not Recruiting NA

  6. Dec 2020 — Jan 2021 [monthly]

    Active Not Recruiting NA

  7. Aug 2019 — Dec 2020 [monthly]

    Active Not Recruiting NA

  8. Nov 2018 — Aug 2019 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  9. Aug 2018 — Nov 2018 [monthly]

    Recruiting NA

  10. Jun 2018 — Aug 2018 [monthly]

    Recruiting NA

  11. Aug 2017 — Jun 2018 [monthly]

    Recruiting NA

  12. May 2017 — Aug 2017 [monthly]

    Recruiting NA

  13. Feb 2017 — May 2017 [monthly]

    Recruiting NA

  14. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Jul 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Dell, Inc.
  • Giselle Sholler
  • Translational Genomics Research Institute
Data source: Milton S. Hershey Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .